Status:
RECRUITING
Advantages of Early Intrauterine Transfer of "Blank" Culture Medium Prior to 1st or 2nd Transfer of Thawed Embryo(s).
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Single Embryo Transfer
Fertilization in Vitro
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Despite technical advances in Medically Assisted Reproduction (AMP), the success of fertility treatments is sometimes limited by embryo implantation failure. The coordinated development of the embryo ...
Eligibility Criteria
Inclusion
- Having had a first "fresh" or frozen embryo transfer, whatever the embryo's stage of development, transfer followed by pregnancy failure ;
- Frozen embryos must be at least D3 stage;
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
Exclusion
- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
- The patient is under safeguard of justice or state guardianship
Key Trial Info
Start Date :
February 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
1154 Patients enrolled
Trial Details
Trial ID
NCT06177613
Start Date
February 9 2024
End Date
February 1 2027
Last Update
February 20 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Antoine Béclère
Clamart, France
2
Centre Hospitalier Alpes Léman
Contamine-sur-Arve, France
3
CHU Arnaud de Villeneuve
Montpellier, France
4
Clinique Saint Roch
Montpellier, France